3-methoxytyramine has been researched along with Amphetamine-Related Disorders in 1 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kita, T | 1 |
| Matsunari, Y | 1 |
| Saraya, T | 1 |
| Shimada, K | 1 |
| O'Hara, K | 1 |
| Kubo, K | 1 |
| Wagner, GC | 1 |
| Nakashima, T | 1 |
1 other study available for 3-methoxytyramine and Amphetamine-Related Disorders
| Article | Year |
|---|---|
Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Behavior, Animal; Body Tempe | 2000 |